Cargando…
Optimal First-Line Medico-Surgical Strategy in Ovarian Cancers: Are We There Yet?
SIMPLE SUMMARY: Cytoreductive surgery represents the cornerstone of the management of advanced epithelial ovarian cancers (aEOC). Currently, two alternative strategies coexist: either primary cytoreductive surgery (PCS) followed by adjuvant systemic therapy or neoadjuvant chemotherapy (NACT) followe...
Autores principales: | Quesada, Stanislas, Thomas, Quentin Dominique, Colombo, Pierre-Emmanuel, Fiteni, Frederic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377152/ https://www.ncbi.nlm.nih.gov/pubmed/37509219 http://dx.doi.org/10.3390/cancers15143556 |
Ejemplares similares
-
Cancer-Related Alopecia: From Etiologies to Global Management
por: Quesada, Stanislas, et al.
Publicado: (2021) -
Are we there yet?
por: Wise, Jo Ann
Publicado: (2015) -
Are we there yet?
por: Swann, Nicole
Publicado: (2019) -
Are we there yet?
por: McCann, Shaun R.
Publicado: (2022) -
Urine Biomarkers for the Early Detection of Ovarian Cancer – Are We There Yet?
por: Grayson, Kelly, et al.
Publicado: (2019)